PO-1078 Superparamagnetic Iron Oxide Nanoparticle Mediated Radiosensitization at Megavoltage Radiation
Bildiriler > Özet Bildiri
Yazarlar: E. Korkmaz Kıraklı, G. Takan, Sinan HOCA, Fazilet Zümrüt BİBER MÜFTÜLER, Ayfer YURT KILÇAR, S. Arun Kamer, Yavuz ANACAK
Radiotherapy and Oncology, , , Uluslararası, Özet Bildiri, Wos, cilt 133, ss S599-S599
DOI: 10.1016/s0167-8140(19)31498-7
Özet
ConclusionNSCLC is a heterogeneous disease, with differences in mutational status, expression of metabolism-related markers between AC and SCC but also within AC subtypes, and response to metabolic inhibition.GLUT1 and SLC1A5 expression correlated with aggressive tumor behavior only in AC.So, these markers could select a group of AC patients that require intensification of treatment.Only a part of NSCLC patients may benefit from the combination of radiation therapy and metabolic inhibition, making stratification necessary.